Altehoefer C, Blum U, Bathmann J, Wüstenberg C, Uhrmeister P, Laubenberger J, Lange W, Schwarzkopf J, Moser E, Langer M
Department of Diagnostic Radiology, University Hospital Freiburg, Germany.
J Clin Oncol. 1997 May;15(5):1754-60. doi: 10.1200/JCO.1997.15.5.1754.
To compare the diagnostic accuracy of magnetic resonance imaging (MRI) and immunoscintigraphy (IS) for detection of bone marrow infiltration in malignant lymphoma.
In 32 patients with Hodgkin's disease (HD) or non-Hodgkin's lymphoma (NHL), MRI of the axial skeleton and whole-body IS using technetium-99m (99mTc)-labeled monoclonal antibodies were reviewed and compared with iliac crest biopsies. Criterion for marrow infiltration was a positive biopsy or concordant positive results of MRI and IS.
In 16 patients (50%), MRI, IS, and iliac crest biopsies were negative for marrow infiltration. Iliac crest biopsy showed infiltration in only four patients (13%). Infiltration was missed in two of 32 patients with IS and in one patient with MRI. In one additional patient, MRI was false-positive because of pelvic hematopoietic hyperplasia. A subset of nine patients (28%) with negative biopsies had bone marrow involvement according to MRI and IS with identical location and pattern of infiltration. In eight of these nine patients, diagnostic imaging indicated marrow involvement only in noncrest marrow. Subsequent biopsy confirmed infiltration in five patients. The clinical course suggested true-positive imaging results in the remaining four patients. Two patients (6%) remained equivocal. Overall concordance of MRI and IS for marrow infiltration was 88% (28 of 32 patients).
Diagnostic imaging is essential for optimal staging in malignant lymphoma, as blind biopsies appear to have low sensitivity for bone marrow infiltration because of frequent involvement in noncrest marrow. both imaging modalities show a high rate of detection of bone marrow infiltration.
比较磁共振成像(MRI)和免疫闪烁显像(IS)检测恶性淋巴瘤骨髓浸润的诊断准确性。
对32例霍奇金病(HD)或非霍奇金淋巴瘤(NHL)患者进行了研究,回顾了其脊柱轴位MRI及使用锝-99m(99mTc)标记单克隆抗体的全身IS检查结果,并与髂嵴活检结果进行比较。骨髓浸润的标准为活检阳性或MRI与IS结果一致呈阳性。
16例患者(50%)的MRI、IS及髂嵴活检均显示无骨髓浸润。髂嵴活检仅显示4例患者(13%)有浸润。32例患者中,IS漏诊2例,MRI漏诊1例。另外,1例患者因盆腔造血增生导致MRI出现假阳性结果。9例活检阴性的患者(28%)根据MRI和IS显示有骨髓受累,浸润部位和模式相同。这9例患者中有8例,诊断性影像学检查仅显示非嵴骨髓有受累。随后的活检证实5例患者有浸润。临床病程提示其余4例患者影像学检查结果为真阳性。2例患者(6%)结果仍不明确。MRI和IS对骨髓浸润的总体一致性为88%(32例患者中的28例)。
诊断性影像学检查对恶性淋巴瘤的最佳分期至关重要,因为由于非嵴骨髓频繁受累,盲目活检对骨髓浸润的敏感性似乎较低。两种影像学检查方式对骨髓浸润均显示出较高的检出率。